Scandion Oncology A/S (“Scandion Oncology”) hereby announces that Jørgen Bardenfleth will continue as Chairman of the Board and Peter Høngaard Andersen will take over the position as Vice-Chairman of the Board.
CEO of Scandion Oncology, Nils Brünner:
“I am delighted that Jørgen Bardenfleth has accepted to continue as Chairman of the Board”.
Our new Board member, Dr. Peter Høngaard Andersen has accepted to take over the position as Vice-Chairman of the Board. With Peters many years of experience from pharma and biotech and his recent position as Managing Director of Innovation Fund